The discovery and development of SU14813, a next-generation multitargeted tyrosine kinase inhibitor for the treatment of human malignancies

Mol Cancer Ther. 2011 Nov;10(11):2015. doi: 10.1158/1535-7163.MCT-11-0722.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Indoles / therapeutic use*
  • Morpholines / therapeutic use*
  • Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Indoles
  • Morpholines
  • Protein Kinase Inhibitors
  • Receptor Protein-Tyrosine Kinases